Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

Recruiting now · Not applicable

Conditions studied: Cancer

In brief

This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.

Key facts

Study ID

NCT06997185

Run by

London School of Economics and Political Science

People needed

3000

Starts

2025-05-09

Expected to finish

2025-06-01

Last updated by the study team

2025-05-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults 18 years of age and older
• Adults fluent in English
• Adults residing in the United States

You may not qualify if…

• Participants who do not meet each of the 3 inclusion criteria

Where it is running

• Harvard Medical School and Harvard Pilgrim Health Care Institute — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.